Fluoxetine Opens Window to Improve Motor Recovery After Stroke

NCT03448159 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Stroke
Cerebrovascular Accident
Cerebral Infarction
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases

Interventions

DRUG: Fluoxetine Hydrochloride
OTHER: Placebo
BEHAVIORAL: Exercise Program

Sponsor

University Health Network, Toronto

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]